China OK for STAAR's Visian ICL (implantable collamer lens)
This article was originally published in Clinica
Executive Summary
Staar Surgical has received market approval from the State Food and Drug Administration (SFDA) of the People's Republic of China for its minimally-invasive foldable lens for treating myopia (near-sightedness) and astigmatism. The "Visian ICL" (implantable collamer lens), which has already received market clearance in 43 countries, including the US and Europe, will be the first of its kind approved for sale in China.